Wanbury Ltd, one of India’s fast growing pharmaceutical company having a presence in API global market and domestic branded formulation today announced the successful completion of the United States Food & Drug Administration (USFDA) inspection at Patalganga site, Maharashtra. The inspection that started from Monday,
Wanbury Ltd., one of India’s fastest growing pharmaceutical company having a presence in API global market and domestic branded Formulation, announced its financial results for the fourth quarter and year ended March 31, 2024. Consolidated Q4 & FY24 Financial Highlights
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
